Parkville, MO · Founded 2015 · Privately Held (backing)
Developer of small molecule-based therapeutics designed to prevent and treat ion-related human diseases. Bond Biosciences is based in Parkville, MO and was founded in 2015. Its last reported valuation was $122 million in Jan 2022. It has raised $17.1 million across 2 recorded rounds; the latest was a $5.9 million early-stage round in Apr 2026.
Last reported valuation
$121.8M
Oct 2026
Priced at
—
Total raised
$17.1M
Last round
Early Stage VC
Apr 2026
Team — not yet on record
No current team members for Bond Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bond Biosciences with a free account
·Watch Bond Biosciences: the Monday email on marks, rounds and moves
